GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Long-Term Debt & Capital Lease Obligation

Charmacy Pharmaceutical Co (HKSE:02289) Long-Term Debt & Capital Lease Obligation : HK$52 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Long-Term Debt & Capital Lease Obligation?

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Charmacy Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$52 Mil.

Warning Sign:

Charmacy Pharmaceutical Co Ltd keeps issuing new debt. Over the past 3 years, it issued CNY 62.217 million of debt.

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligation divides by its Total Assets. Charmacy Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$52 Mil. Charmacy Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2024 was HK$3,691 Mil. Charmacy Pharmaceutical Co's LT-Debt-to-Total-Asset for the quarter that ended in Dec. 2024 was 0.01.

Charmacy Pharmaceutical Co's LT-Debt-to-Total-Asset increased from Dec. 2023 (0.01) to Dec. 2024 (0.01). It may suggest that Charmacy Pharmaceutical Co is progressively becoming more dependent on debt to grow their business.


Charmacy Pharmaceutical Co Long-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Long-Term Debt & Capital Lease Obligation Chart

Charmacy Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 158.60 121.66 17.59 33.24 52.29

Charmacy Pharmaceutical Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Long-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.59 15.09 33.24 42.69 52.29

Charmacy Pharmaceutical Co Long-Term Debt & Capital Lease Obligation Calculation

Long-Term Debt is the debt due more than 12 months in the future. The debt can be owed to banks or bondholders. Some companies issue bonds to investors and pay interest on the bonds.

Long-Term Capital Lease Obligation represents the total liability for long-term leases lasting over one year. It's amount equal to the present value (the principal) at the beginning of the lease term less lease payments during the lease term.

The interest paid on companies' debt is reflected in the income statement as interest expense. If a company has too much debt and it cannot serve the interest payment on the debt or repay the matured debt, the company risks bankruptcy. Peter Lynch famously said: A company that does not have debt cannot go bankrupt.

A company's long term debt may have different dates of maturity and interest rates, depending on the terms.

Usually a company issues long term debt to pay for its capital expenditures. Borrowing allows the company to do things that otherwise cannot be done with only the capital it has. But debt can be risky.


Charmacy Pharmaceutical Co  (HKSE:02289) Long-Term Debt & Capital Lease Obligation Explanation

LT-Debt-to-Total-Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Charmacy Pharmaceutical Co's LT-Debt-to-Total-Asset ratio for the quarter that ended in Dec. 2024 is calculated as:

LT-Debt-to-Total-Asset (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=52.286/3690.562
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Buffett says that durable competitive advantages carry little to no long-term debt because the company is so profitable that even expansions or acquisitions are self financed.

We are interested in long term debt load for the last ten years. If the ten years of operation show little to no long term debt, then the company has some kind of strong competitive advantage.

Warren Buffett's historic purchases indicate that on any given year, the company should have sufficient yearly net earnings to pay all long term within 3 or 4 year earnings period. (e.g. Coke + Moody's = 1yr)

Companies with enough earning power to pay long term debt in less than 3 or 4 years is a good candidate in our search for long term competitive advantage.

BUT, these companies are targets for leveraged buy outs, which saddles the business with long term debt.

If all else indicates the company has a moat, but it has ton of debt, a leveraged buyout may have created the debt. In these cases the company's bonds offer the better bet, in that the company’s earnings power is focused on paying off the debt and not growth.

Important: little or no long term debt often means a Good Long Term Bet


Charmacy Pharmaceutical Co Long-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Charmacy Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes Western medicine, Chinese patent medicine, and healthcare products to downstream distributors and retail terminals while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products-related consulting services. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
Executives
Jiangxi Pharmaceutical Investment Co., Limited 2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si 2201 Interest of corporation controlled by you
Yao Chuanglong 2101 Beneficial owner
You Zeyan 2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si 2101 Beneficial owner
Rays Capital Partners Limited 2102 Investment manager
Ruan David Ching Chi 2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited 2101 Beneficial owner
Wang Yonghui 2101 Beneficial owner

Charmacy Pharmaceutical Co Headlines

No Headlines